[HTML][HTML] Silymarin and caffeine combination ameliorates experimentally-induced hepatic fibrosis through down-regulation of LPAR1 expression

SM Eraky, M El-Mesery, A El-Karef, LA Eissa… - Biomedicine & …, 2018 - Elsevier
Aims Lysophosphatidic acid is a lipid mediator that is supposed to be implicated in hepatic
fibrosis. Silymarin and caffeine are natural compounds known for their anti-inflammatory and …

Silymarin and caffeine combination ameliorates experimentally-induced hepatic fibrosis through down-regulation of LPAR1 expression.

SM Eraky, M El-Mesery, A El-Karef… - Biomedicine & …, 2018 - europepmc.org
Lysophosphatidic acid is a lipid mediator that is supposed to be implicated in hepatic
fibrosis. Silymarin and caffeine are natural compounds known for their anti-inflammatory and …

Silymarin and caffeine combination ameliorates experimentally-induced hepatic fibrosis through down-regulation of LPAR1 expression.

SM Eraky, M El-Mesery, A El-Karef, LA Eissa… - 2018 - cabidigitallibrary.org
Aims: Lysophosphatidic acid is a lipid mediator that is supposed to be implicated in hepatic
fibrosis. Silymarin and caffeine are natural compounds known for their anti-inflammatory and …

Silymarin and caffeine combination ameliorates experimentally-induced hepatic fibrosis through down-regulation of LPAR1 expression

SM Eraky, M El-Mesery, A El-Karef… - Biomedicine & …, 2018 - pubmed.ncbi.nlm.nih.gov
Aims Lysophosphatidic acid is a lipid mediator that is supposed to be implicated in hepatic
fibrosis. Silymarin and caffeine are natural compounds known for their anti-inflammatory and …